Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19892
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAsproudis, I.en
dc.contributor.authorGorezis, S.en
dc.contributor.authorCharonis, G. C.en
dc.contributor.authorTolis, C.en
dc.contributor.authorTsanou, E.en
dc.contributor.authorAgnantis, N. J.en
dc.date.accessioned2015-11-24T19:03:23Z-
dc.date.available2015-11-24T19:03:23Z-
dc.identifier.issn0258-851X-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19892-
dc.rightsDefault Licence-
dc.subjectAgeden
dc.subjectAnti-Inflammatory Agents/therapeutic useen
dc.subjectAntibodies, Monoclonal/therapeutic useen
dc.subjectAntibodies, Monoclonal, Murine-Deriveden
dc.subjectAntigens, CD20/metabolismen
dc.subjectBiopsyen
dc.subjectFollow-Up Studiesen
dc.subjectHumansen
dc.subjectImmunohistochemistryen
dc.subjectLacrimal Apparatus/*pathology/radiography/surgeryen
dc.subjectLymphoma, B-Cell, Marginal Zone/diagnosis/*pathology/radiography/surgeryen
dc.subjectMaleen
dc.subjectMethylprednisolone/therapeutic useen
dc.subjectTime Factorsen
dc.subjectTomography, X-Ray Computeden
dc.subjectTreatment Outcomeen
dc.titleMucosa-associated lymphoid tissue lymphoma of the lacrimal gland--a case reporten
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/16277031-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2005-
heal.abstractMALT lymphoma of the ocular adnexa, an indolent B-cell lymphoma, rarely affects the lacrimal gland. The case of a 73-year-old man with ptosis and edema of the left upper eyelid, due to lacrimal gland swelling, is presented. Clinical evaluation and imaging examination led to excision biopsy. The mass histopathology, presenting organized lymphoid tissue, composed mainly of small B-cells, accompanied by immunophenotypic characteristics, was compatible with MALT lymphoma. Treatment with monoclonal antibody against CD-20 achieved a successful long-term disease control (4 years). The diagnostic approach is described and the pathological features and clinical signs of this rare entity are discussed, based on recent literature. The indolent clinical course of this lymphoma, either remaining localized or disseminating to other mucosal sites, is a distinct characteristic affecting prognosis.en
heal.journalNameIn Vivoen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons